The pathophysiology of the severe complications of COVID-19 is still unclear. We report preliminary data providing evidence of complement activation in patients with COVID-19 with different degrees of respiratory failure.

Complement activation in patients with COVID-19: a novel therapeutic target / M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, M. Panigada, S. Aliberti, F. Blasi, F. Tedesco, F. Peyvandi. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 0091-6749. - (2020). [Epub ahead of print] [10.1016/j.jaci.2020.05.006]

Complement activation in patients with COVID-19: a novel therapeutic target

M. Cugno
Primo
Conceptualization
;
P.L. Meroni
Secondo
Conceptualization
;
R. Gualtierotti
Conceptualization
;
S. Griffini
Conceptualization
;
S. Aliberti
Conceptualization
;
F. Blasi
Conceptualization
;
F. Peyvandi
Ultimo
Supervision
2020

Abstract

The pathophysiology of the severe complications of COVID-19 is still unclear. We report preliminary data providing evidence of complement activation in patients with COVID-19 with different degrees of respiratory failure.
C5a; COVID-19; Complement; SARS-CoV-2; sC5b-9
Settore MED/10 - Malattie dell'Apparato Respiratorio
Settore MED/09 - Medicina Interna
14-mag-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0091674920306503-main.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 2.11 MB
Formato Adobe PDF
2.11 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/735686
Citazioni
  • ???jsp.display-item.citation.pmc??? 135
  • Scopus 144
  • ???jsp.display-item.citation.isi??? 139
social impact